The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of the PI3 kinase inhibitor BKM120 with or without enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC).
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Susan Halabi
Research Funding - Sanofi (Inst)
 
Patrick Healy
No Relationships to Disclose
 
Joshi J. Alumkal
Research Funding - Astellas Pharma (Inst)
 
Evan Y. Yu
Honoraria - Amgen; Bayer; Dendreon; Janssen; Medivation; Sanofi
Consulting or Advisory Role - Amgen; Dendreon; Janssen; Medivation; Sanofi
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); GTx (Inst); ImClone Systems (Inst); Janssen (Inst); Oncogenex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dendreon; Janssen; Medivation
 
Carolyn Winters
No Relationships to Disclose
 
Carey Hobbs
No Relationships to Disclose
 
Colleen Soleau
No Relationships to Disclose
 
Rachel Slottke
No Relationships to Disclose
 
Kelly Mundy
No Relationships to Disclose
 
Daniel J. George
Honoraria - Algeta ASA; Amgen; Astellas Pharma; AVEO; Dendreon; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Algeta ASA; Astellas Pharma; Aveo; Bayer; BIND Biosciences; Dendreon; Exelixis; GlaxoSmithKline; Medivation; Novartis; Pfizer; progenics; Sanofi; Viamet Pharmaceuticals
Speakers' Bureau - Dendreon; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Progenics (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Algeta/Bayer; Astellas Pharma; AVEO; Bristol-Myers Squibb; Dendreon; Pfizer; Progenics; Sanofi